HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 09-MAY-19 6OWC TITLE MUTANT ESTROGEN RECEPTOR ALPHA (ERA) Y537S COVALENTLY BOUND TO H3B- TITLE 2 6545. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR HORMONE RECEPTOR, H3B-6545, INHIBITOR, SERM, TRANSCRIPTION, KEYWDS 2 TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.A.LARSEN REVDAT 2 11-OCT-23 6OWC 1 REMARK REVDAT 1 19-JUN-19 6OWC 0 JRNL AUTH C.FURMAN JRNL TITL MUTANT ESTROGEN RECEPTOR ALPHA (ERA) Y537S COVALENTLY BOUND JRNL TITL 2 TO H3B-6545. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 43768 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2310 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2982 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 162 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3769 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 284 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.132 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.132 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.778 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3988 ; 0.020 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3843 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5388 ; 2.044 ; 2.003 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8912 ; 1.298 ; 3.005 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 483 ; 6.975 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 163 ;39.028 ;24.294 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 756 ;15.451 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;19.357 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 620 ; 0.125 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4278 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 755 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1917 ; 3.553 ; 3.243 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1916 ; 3.554 ; 3.241 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2396 ; 5.034 ; 4.823 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2397 ; 5.033 ; 4.825 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2071 ; 4.635 ; 3.784 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2071 ; 4.635 ; 3.784 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2990 ; 6.755 ; 5.450 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4615 ; 8.733 ;38.986 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4616 ; 8.732 ;38.988 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6OWC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-MAY-19. REMARK 100 THE DEPOSITION ID IS D_1000241459. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-SEP-17 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46101 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 73.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6CHW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40% PEG 1000, 60 MM NACL, 0.1 M TAPS REMARK 280 PH 9.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.99000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 41.73000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 41.73000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 113.98500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 41.73000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 41.73000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 37.99500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 41.73000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.73000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 113.98500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 41.73000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.73000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 37.99500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 75.99000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 297 REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 HIS A 547 REMARK 465 ARG A 548 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 GLY B 297 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 VAL B 534 REMARK 465 PRO B 535 REMARK 465 LEU B 536 REMARK 465 HIS B 547 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 826 O HOH A 832 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 456 CB SER A 456 OG 0.086 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 436 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG A 515 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG B 352 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 MET B 396 CG - SD - CE ANGL. DEV. = 14.7 DEGREES REMARK 500 ARG B 412 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG B 436 NE - CZ - NH1 ANGL. DEV. = 4.8 DEGREES REMARK 500 ARG B 436 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG B 477 CB - CG - CD ANGL. DEV. = 18.8 DEGREES REMARK 500 ARG B 477 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 LEU B 495 CB - CG - CD1 ANGL. DEV. = 10.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 419 104.86 -50.63 REMARK 500 PHE B 461 -69.73 -121.82 REMARK 500 LYS B 529 49.67 70.96 REMARK 500 ASP B 545 61.96 89.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 545 ALA A 546 145.22 REMARK 500 ASP B 538 LEU B 539 144.93 REMARK 500 LEU B 544 ASP B 545 145.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ND1 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ND1 B 601 and CYS B REMARK 800 530 DBREF 6OWC A 298 554 UNP P03372 ESR1_HUMAN 298 554 DBREF 6OWC B 298 554 UNP P03372 ESR1_HUMAN 298 554 SEQADV 6OWC GLY A 297 UNP P03372 EXPRESSION TAG SEQADV 6OWC SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 6OWC SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 6OWC GLY B 297 UNP P03372 EXPRESSION TAG SEQADV 6OWC SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 6OWC SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 258 GLY ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER SEQRES 2 A 258 LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA SEQRES 3 A 258 GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG SEQRES 4 A 258 PRO PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN SEQRES 5 A 258 LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA SEQRES 6 A 258 LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP SEQRES 7 A 258 GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU ILE LEU SEQRES 8 A 258 MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY SEQRES 9 A 258 LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN SEQRES 10 A 258 GLN GLY LYS SER VAL GLU GLY MET VAL GLU ILE PHE ASP SEQRES 11 A 258 MET LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN SEQRES 12 A 258 LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE SEQRES 13 A 258 LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR SEQRES 14 A 258 LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL SEQRES 15 A 258 LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA SEQRES 16 A 258 LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU SEQRES 17 A 258 ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SEQRES 18 A 258 SER ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CYS SEQRES 19 A 258 LYS ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET SEQRES 20 A 258 LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 B 258 GLY ILE LYS ARG SER LYS LYS ASN SER LEU ALA LEU SER SEQRES 2 B 258 LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU ASP ALA SEQRES 3 B 258 GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO THR ARG SEQRES 4 B 258 PRO PHE SER GLU ALA SER MET MET GLY LEU LEU THR ASN SEQRES 5 B 258 LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN TRP ALA SEQRES 6 B 258 LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU HIS ASP SEQRES 7 B 258 GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU GLU ILE LEU SEQRES 8 B 258 MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS PRO GLY SEQRES 9 B 258 LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN SEQRES 10 B 258 GLN GLY LYS SER VAL GLU GLY MET VAL GLU ILE PHE ASP SEQRES 11 B 258 MET LEU LEU ALA THR SER SER ARG PHE ARG MET MET ASN SEQRES 12 B 258 LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER ILE ILE SEQRES 13 B 258 LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SER THR SEQRES 14 B 258 LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL SEQRES 15 B 258 LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU MET ALA SEQRES 16 B 258 LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN ARG LEU SEQRES 17 B 258 ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG HIS MET SEQRES 18 B 258 SER ASN LYS GLY MET GLU HIS LEU TYR SER MET LYS CYS SEQRES 19 B 258 LYS ASN VAL VAL PRO LEU SER ASP LEU LEU LEU GLU MET SEQRES 20 B 258 LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER HET ND1 A 601 41 HET ND1 B 601 41 HET EDO B 602 4 HETNAM ND1 (2Z)-N,N-DIMETHYL-4-{[2-({5-[(1Z)-4,4,4-TRIFLUORO-1-(3- HETNAM 2 ND1 FLUORO-2H-INDAZOL-5-YL)-2-PHENYLBUT-1-EN-1-YL]PYRIDIN- HETNAM 3 ND1 2-YL}OXY)ETHYL]AMINO}BUT-2-ENAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 ND1 2(C30 H29 F4 N5 O2) FORMUL 5 EDO C2 H6 O2 FORMUL 6 HOH *284(H2 O) HELIX 1 AA1 SER A 305 LEU A 310 1 6 HELIX 2 AA2 THR A 311 GLU A 323 1 13 HELIX 3 AA3 SER A 338 VAL A 364 1 27 HELIX 4 AA4 GLY A 366 LEU A 370 5 5 HELIX 5 AA5 THR A 371 SER A 395 1 25 HELIX 6 AA6 ARG A 412 LYS A 416 1 5 HELIX 7 AA7 GLY A 420 MET A 438 1 19 HELIX 8 AA8 GLN A 441 SER A 456 1 16 HELIX 9 AA9 GLU A 470 ALA A 493 1 24 HELIX 10 AB1 THR A 496 LYS A 529 1 34 HELIX 11 AB2 PRO A 535 ALA A 546 1 12 HELIX 12 AB3 SER B 305 LEU B 310 5 6 HELIX 13 AB4 THR B 311 ALA B 322 1 12 HELIX 14 AB5 SER B 338 ARG B 363 1 26 HELIX 15 AB6 THR B 371 SER B 395 1 25 HELIX 16 AB7 ARG B 412 LYS B 416 1 5 HELIX 17 AB8 GLY B 420 MET B 438 1 19 HELIX 18 AB9 GLN B 441 ASN B 455 1 15 HELIX 19 AC1 THR B 465 ALA B 493 1 29 HELIX 20 AC2 THR B 496 MET B 528 1 33 HELIX 21 AC3 ASP B 538 ASP B 545 1 8 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK SG CYS A 530 C5 ND1 A 601 1555 1555 1.61 LINK SG CYS B 530 C5 ND1 B 601 1555 1555 1.64 CISPEP 1 MET A 528 LYS A 529 0 -7.66 SITE 1 AC1 17 MET A 343 LEU A 346 THR A 347 ALA A 350 SITE 2 AC1 17 ASP A 351 GLU A 353 TRP A 383 LEU A 387 SITE 3 AC1 17 MET A 388 LEU A 391 PHE A 404 ILE A 424 SITE 4 AC1 17 LEU A 428 GLY A 521 TYR A 526 LYS A 529 SITE 5 AC1 17 CYS A 530 SITE 1 AC2 8 ARG A 434 GLN A 506 LEU A 509 HOH A 735 SITE 2 AC2 8 HIS B 476 LEU B 479 ASP B 480 HOH B 756 SITE 1 AC3 19 LEU B 346 THR B 347 ALA B 350 GLU B 353 SITE 2 AC3 19 LEU B 387 MET B 388 LEU B 391 ARG B 394 SITE 3 AC3 19 PHE B 404 MET B 421 ILE B 424 PHE B 425 SITE 4 AC3 19 LEU B 428 GLY B 521 LEU B 525 MET B 528 SITE 5 AC3 19 LYS B 529 LYS B 531 HOH B 730 CRYST1 83.460 83.460 151.980 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011982 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011982 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006580 0.00000